US Testing Monoclonal Antibodies Paused
A US clinical trial testing monoclonal antibodies to treat Covid-19 has been paused for safety concerns.
The treatment has been developed by drug company Eli Lily, and is similar to the one Donald Trump received after testing positive for coronavirus (his was from biotech company Regeneron).
The therapy involves giving patients laboratory-made antibodies that boost the immu
Temporarily stopping a clinical trial, to properly investigate if, for example, a person has become ill, is a vital part of that process. We’ve already seen a pause with the Oxford vaccine trial, and more recently with Johnson & Johnson’s vaccine candidate – and this stop-start process is likely to happen with new treatments like monoclonal antibodies too.
